Anagenics Ltd (AN1) - Total Liabilities

Latest as of December 2025: AU$1.82 Million AUD ≈ $1.29 Million USD

Based on the latest financial reports, Anagenics Ltd (AN1) has total liabilities worth AU$1.82 Million AUD (≈ $1.29 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Anagenics Ltd - Total Liabilities Trend (2006–2025)

This chart illustrates how Anagenics Ltd's total liabilities have evolved over time, based on quarterly financial data. See AN1 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Anagenics Ltd Competitors by Total Liabilities

The table below lists competitors of Anagenics Ltd ranked by their total liabilities.

Company Country Total Liabilities
Aston Martin Lagonda Global Holdings PLC
LSE:AML
UK GBX2.48 Billion
Luceco plc
LSE:LUCE
UK GBX151.60 Million
Conferize A/S
CO:CONFRZ
Denmark Dkr2.65 Million
Samchai Steel Industries Public Company Limited
BK:SAM
Thailand ฿2.41 Billion
Elkop SA
WAR:EKP
Poland zł22.00K
Buff Technologies Ltd
TA:BUFT
Israel ILA4.66 Million
Golden Metal Resources PLC
LSE:GMET
UK GBX1.78 Million
Astrotech Corp
NASDAQ:ASTC
USA $4.18 Million

Liability Composition Analysis (2006–2025)

This chart breaks down Anagenics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AN1 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.10 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.16 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.80 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.45 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Anagenics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Anagenics Ltd (2006–2025)

The table below shows the annual total liabilities of Anagenics Ltd from 2006 to 2025.

Year Total Liabilities Change
2025-06-30 AU$2.28 Million
≈ $1.61 Million
-34.66%
2024-06-30 AU$3.48 Million
≈ $2.46 Million
+57.09%
2023-06-30 AU$2.22 Million
≈ $1.57 Million
-52.18%
2022-06-30 AU$4.64 Million
≈ $3.28 Million
+62.14%
2021-06-30 AU$2.86 Million
≈ $2.02 Million
-43.70%
2020-06-30 AU$5.08 Million
≈ $3.59 Million
+29.04%
2019-06-30 AU$3.93 Million
≈ $2.78 Million
-19.59%
2018-06-30 AU$4.89 Million
≈ $3.46 Million
+20.01%
2017-06-30 AU$4.08 Million
≈ $2.88 Million
+49.64%
2016-06-30 AU$2.72 Million
≈ $1.93 Million
+14.79%
2015-06-30 AU$2.37 Million
≈ $1.68 Million
+200.19%
2014-06-30 AU$790.70K
≈ $559.47K
+14.83%
2013-06-30 AU$688.56K
≈ $487.20K
+60.59%
2012-06-30 AU$428.78K
≈ $303.39K
-45.30%
2011-06-30 AU$783.90K
≈ $554.66K
+112.26%
2010-06-30 AU$369.31K
≈ $261.31K
-23.66%
2009-06-30 AU$483.80K
≈ $342.32K
-75.64%
2008-06-30 AU$1.99 Million
≈ $1.41 Million
-37.60%
2007-06-30 AU$3.18 Million
≈ $2.25 Million
+505.60%
2006-06-30 AU$525.45K
≈ $371.79K
--

About Anagenics Ltd

AU:AN1 Australia Household & Personal Products
Market Cap
$4.88 Million
AU$6.90 Million AUD
Market Cap Rank
#28617 Global
#1550 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$0.70
About

Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pac… Read more